Gonzalo Martínez-Alés Awarded New Suicide Research Grant
CAUSALab & Mount Sinai Health System researcher Gonzalo Martínez-Alés was awarded a new grant by the American Foundation for Suicide Prevention in June 2024.
“Effectiveness of Pharmacological Interventions to Prevent Suicidal Behaviors Among Individuals at High Suicide Risk: A Target Trial Emulation” (Grant ECR-1-101-23) aims to apply innovative target trial emulation design using big data from EMR to investigate the relationship of medications with suicide risk.
CAUSALab Director Miguel Hernán will serve as a mentor alongside M. Mercedes Perez-Rodriguez from Mount Sinai Health System and Enrique Baca-Garcia from Universidad Autónoma de Madrid.
